Video index

1. Call to order

2. Consideration of January 23, 2026, draft meeting minutes

3. Consideration of revised draft Drug Utilization Review Board (DURB) Bylaws

4. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL):

5. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL:

6. Therapeutic and clinical drug reviews and updates, discussion, and recommendations: Gainwell Technologies and DURB members

7. Executive work session

8. Announcements of drugs recommended for the Medicaid PDL: OptumRx

9. Prospective prior authorization proposals: Acentra Health

10. Retrospective drug utilization review (DUR): Acentra Health

11. Retrospective drug use criteria for outpatient use in Vendor Drug Program: The University of Texas at Austin College of Pharmacy

12. Review of action items for next meeting: July 24, 2026, 9:00 a.m.

Apr 24, 2026 Drug Utilization Review Board (DURB)

Full agenda
Share this video

1. Call to order

2. Consideration of January 23, 2026, draft meeting minutes

3. Consideration of revised draft Drug Utilization Review Board (DURB) Bylaws

4. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL):

5. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL:

6. Therapeutic and clinical drug reviews and updates, discussion, and recommendations: Gainwell Technologies and DURB members

7. Executive work session

8. Announcements of drugs recommended for the Medicaid PDL: OptumRx

9. Prospective prior authorization proposals: Acentra Health

10. Retrospective drug utilization review (DUR): Acentra Health

11. Retrospective drug use criteria for outpatient use in Vendor Drug Program: The University of Texas at Austin College of Pharmacy

12. Review of action items for next meeting: July 24, 2026, 9:00 a.m.

© 2003-2026 Swagit Productions, LLC